Evidence map›Paper›PMID 38256891›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

The Discovery of Novel Agents against

Kang Liu, Jiangbo Tong, Xu Liu, Dan Liang, Fangzhe Ren, Nan Jiang, Zhenyu Hao, Shixin Li, Qiang Wang

Erratum issuedOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Correction: Liu et al. The Discovery of Novel Agents againstPharmaceuticals (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Kang LiuCollege of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, China.
Jiangbo TongCollege of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, China.
Xu LiuCollege of Chemistry and Chemical Engineering, Yangzhou University, Yangzhou 225009, China.
Dan LiangCollege of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, China.
Fangzhe RenCollege of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, China.
Nan JiangCollege of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, China.
Zhenyu HaoCollege of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, China.ORCID 0000-0001-6418-2921
Shixin LiCollege of Bioscience and Biotechnology, Yangzhou University, Yangzhou 225009, China.
Qiang WangDepartment of the Heart and Great Vessels, Affiliated Hospital of Yangzhou University, Yangzhou 225009, China.
Yangzhou University · CN

Funding

STRUCTURAL BASIS OF SCHNYDER CORNEAL DYSTROPHYR21EY028705 · NEI · WASHINGTON UNIVERSITY · PI LI, WEIKAI, WEISS, JAYNE S · 2018 to 2019
$424k
China Postdoctoral Science Foundation 2023M732983China Postdoctoral Science Foundation EY028705National Natural Science Foundation of China 82370136; 32000093Natural Science Foundation of Jiangsu Province; Jiangsu Specially-Appointed Professor Start-up Funds grant BK20231333NEI NIH HHS R21 EY028705
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bacterial infectiondrug screeningSortase A inhibitorStaphylococcus aureus

Identifiers

PMID38256891
PMCPMC11100315
OpenAlexW4390405381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.